Pfizer (PFE)
(Delayed Data from NYSE)
$29.50 USD
+0.19 (0.65%)
Updated Sep 24, 2024 04:01 PM ET
After-Market: $29.52 +0.02 (0.07%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth C Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 32% (80 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.14 | 2.05 | 9.99 |
Current Quarter Estimate | 0.63 | 37.63 | 61.00 |
Year Ago Quarter Estimate | -0.17 | 12.41 | 54.84 |
Next Quarter Estimate | 0.66 | 38.42 | 63.00 |
Next Year Estimate | 2.85 | 173.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 42.39 | 6.60 | 15.67 |
Next Year | 8.78 | 16.80 | 11.34 |
Last 5 Years | -8.50 | 2.90 | 8.10 |
Next 5 Years | 8.70 | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 21.71 | 22.31 |
Price/Book (MRQ) | 1.89 | 5.90 |
Price/Cash Flow (MRFY) | 9.85 | 12.12 |
Dividend Yield | 5.73% | 2.12% |
Net Profit Margin (TTM) | -4.66% | 18.86% |
Return on Equity (TTM) | 8.42% | 34.56% |
Debt to Equity (MRQ) | 0.65 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.